ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
2.330
-0.010 (-0.43%)
At close: Aug 28, 2025, 4:00 PM
2.360
+0.030 (1.29%)
After-hours: Aug 28, 2025, 4:12 PM EDT

ImmunityBio Stock Forecast

Stock Price Forecast

The 5 analysts that cover ImmunityBio stock have a consensus rating of "Strong Buy" and an average price target of $10.2, which forecasts a 337.77% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $24.

Price Target: $10.2 (+337.77%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$5.00$10.2$8.00$24
Change+114.59%+337.77%+243.35%+930.04%

Analyst Ratings

The average analyst rating for ImmunityBio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy444444
Buy001111
Hold110000
Sell000000
Strong Sell000000
Total555555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$24
Strong BuyMaintains$24+930.04%Aug 26, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$24
Strong BuyMaintains$24+930.04%Aug 19, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$24
Strong BuyMaintains$24+930.04%Aug 14, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$30
Strong BuyMaintains$30+1,187.55%Aug 5, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$30
Strong BuyMaintains$30+1,187.55%Jul 25, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
107.63M
from 14.75M
Increased by 629.94%
Revenue Next Year
225.93M
from 107.63M
Increased by 109.91%
EPS This Year
-0.53
from -0.62
EPS Next Year
-0.36
from -0.53
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
605.00K934.00K240.00K622.00K14.75M107.63M225.93M
Revenue Growth
-72.52%54.38%-74.30%159.17%2,270.58%629.94%109.91%
EPS
-0.59-0.89-1.04-1.15-0.62-0.53-0.36
EPS Growth
-------
Forward PE
-------
No. Analysts
-----77
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High114.9M293.4M
Avg107.6M225.9M
Low98.4M138.0M

Revenue Growth

Revenue Growth20252026202720282029
High
679.0%
172.6%
Avg
629.9%
109.9%
Low
567.6%
28.2%

EPS Forecast

EPS20252026202720282029
High-0.46-0.27
Avg-0.53-0.36
Low-0.63-0.47

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.